Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib
Titel:
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib
Auteur:
Horn, Leora Gettinger, Scott Camidge, D. Ross Smit, Egbert F. Janjigian, Yelena Y. Miller, Vincent A. Pao, William Freiwald, Matthias Fan, Jean Wang, Bushi Chand, Vikram K. Groen, Harry J.M.